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Effects of 1,25(OH)2D3 on compensatory renal growth in the growing
rat. Renal compensatory growth after uninephrectomy (UNX) was
examined in vitamin D replete male 100 g Sprague-Dawley rats. Five
days after UNX, the contralateral kidney wet weight increased by 25%
with the kidney weight/body weight ratio reaching a plateau by day 7
after UNX. The early weight increase was primarily due to an increased
cell number, as evaluated by a stereological technique in perfusion-
fixed kidneys. Twenty pmol l,25(OH)2D3 by daily s.c. injection in-
creased time-averaged l,25(OH)2D3 concentrations 3.3-fold and re-
duced the increment in the kidney weight of UNX pairfed rats
compared to solvent UNX controls. The number of mitoses (whole
kidney and different nephron segments) were significantly reduced by
giving 1,25(OH)2D3 to UNX animals at different levels of food intake.
The effect was also demonstrable in PTX animals on a constant infusion
of exogenous PTH (100 ng/kg/hr 1,34 bPTH by osmotic minipump). The
data suggest that changes of I ,25(OH)2D3 concentration within a
physiologically relevant range modulate compensatory (and possibly
basal) growth of the kidney.
In a renal carcinoma cell line, Nagakura et al [I) showed that
1-alpha-25-dihydroxyvitamin D3 [1,25(OH)2D3J reduced prolif-
eration of cells in monolayer and suppressed clonogenicity in
agar culture. An inhibitory effect of 1 ,25(OH)2D3 on renal cell
proliferation is in keeping with observations in numerous other
proliferating cell systems, both malignant [I, 2] and non-
malignant [3, 4]. More recently, a biphasic effect of I ,25(OH)2
D3 on growth with stimulation at very low and inhibition at
higher concentrations has been documented in some in vitro
systems [5].
In the rat, renal compensatory growth after uninephrectomy
is modulated by calcium, PTH and I ,25(OH)2D3 as shown by
Jobin and Bonjour [61. These authors examined vitamin D-de-
ficient rats and noted stimulation of growth by I ,25(OH)2D3
administered by osmotic minipump. The contrasting inhibitory
effect of relatively low concentrations of I ,25(OH)2D3 found by
Nagakura et al [I] was observed in renal cells grown in the
presence of 1 ,25(OH)2D3 (which is an obligatory component of
fetal calf serum). This consideration led us to the hypothesis
that the results in vitamin D depleted animals [6] might reflect
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the results of supplementation of an essential growth factor and
might not permit conclusions with respect to potential regula-
tory functions of I ,25(OH)2D1 in renal cell proliferation and
growth.
To further address this issue, we did the following: (i)
examined the effects of I ,25(OH)2D3 on renal weight, zonal
architecture, cell number and cell volume after uninephrectomy
in growing, male Sprague-Dawley rats under conditions of
controlled food intake, and (ii) examined the effect of
I ,25(OH)2D1 on cell proliferation in vivo in colchicin pretreated
animals.
Methods
Animals
Unless specified otherwise, 100 g male Sprague-Dawley rats
(Ivanovas Co., Kisslegg/Allgau, Germany) were kept in single
cages in an environment with a controlled light on (12 hr)/light
off (12 hr) cycle and with constant temperature (22°C) and
humidity (70%). In some experiments, animals of different
weights (230, 370, and 480 g) were used to establish age-
dependency of renal compensatory growth. Animals had either
free access to food or were fed as specified below. The diet was
Altromin C 1000 (Altromin Co., Lage/Lippe, Germany) con-
taining 500 U/kg (13 tg/kg) vitamin D3, 0.95% Ca and 0.65% Pi
(wtlwt).
Protocols
Experiment I. Effect of I,25(OH)2D3 on normal renal growth
and compensatory renal growth after uninephrectomy (UNX),
respectively. Under light ether anaesthesia, rats were either
UNX (decapsulation of kidney sparing the adrenal) or sham
operated, that is, renal decapsulation (CO). Animals were
examined at timed intervals as indicated in the Tables and
Figures. At the end of the experiment, animals were weighed,
serum chemistries were measured and organ weights were
determined (wet and dry weight of kidney, liver, heart, spleen,
testis, epididymal fat, and soleus muscle). In all experiments,
groups of 6 to 8 animals were studied. The food conversion ratio
[body weight gain (g)/food consumption (g)1 was calculated as
described [71.
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To study the effect of I ,25(OH)2D3, 20 pmol/l00 g body wt (or
solvent) were administered by once daily s.c. injections for the
duration of the experiment, starting on the first day after UNX.
Experiment 2. Histological analysis of the kidney after uni-
nephrectomy. Animals were operated on as described above.
On the fifth day after surgery, the viscera were fixed by
retrograde vascular perfusion at a pressure of 110 mm Hg after
catheterization of the abdominal aorta. Before fixation the
vascular system was flushed with a dextran solution (Rheomac-
rodexR) containing 0.5 g/liter procaine HCI for two minutes to
improve the microcirculation. The inferior vena cava was
incised to drain the blood. The incision was performed 10
seconds after starting the dextran infusion in order to avoid the
collapse of capillaries caused by low venous pressures. The
vascular system was subsequently perfused with 0.2 M phos-
phate buffer containing 3% paraformaldehyde for 12 minutes.
Experiment 3. Influence of 1,25(OH),D3 on mitoses in kid-
neys of parathyroid intact rats. Animals were operated as
described above. On the second day after UNX animals re-
ceived 5 i.p. injections of colchicin (DemecolcinR; Serva Co.,
Heidelberg, Germany) or solvent at 30-minute intervals prior to
the end of the experiment in the forenoon hours (yielding a total
colchicin dose of 800 ig). Kidneys were excised under ether
anaesthesia and fixed in 5% buffered formalin.
l,25(OH)2D3 treated animals consumed less food. Since in a
pilot experiment in animals on unrestricted food intake
l,25(OH)2D3 treatment had diminished mitoses in proximal
tubule cells, we restricted food intake in solvent treated ani-
mals; they received 60% of the food consumed on the day
before by matched l,25(OH)2D3 treated animals. Partial food
deprivation in controls was chosen to exclude the possibility
that reduction of mitoses in I ,25(OH)2D3 treated animals was
only the result of lower food intake.
Experiment 4. Influence of 1 ,25(OH)2D on mitoses in kid-
neys of parathyroidectomized rats maintained on PTH by
osmotic minipump. Parathyroids were removed using microsur-
gical techniques. At the time of surgery 100 ng/kg/hr of 1,34
bPTH (Bissendorf Co., Wedemark, Germany) was adminis-
tered by s.c. osmotic minipump (Alzet Co., model 2 ML 1; 1,34
bPTH was dissolved in cystein hydrochloride). UNX was
performed on the fifth day after PTX. Subsequently, animals
were given either solvent or 20 pmol/lOO g body wt of
l,25(OH)2D3 by daily s.c. injection. Animals were on ad libitum
food intake. After colchicin treatment (experiment 3) the exper-
iment was terminated on the seventh day after PTX. Animals
were kept on Altromin C 1000 diet throughout the experiment.
Kidneys were prepared for counting of mitoses as described in
experiment 3. The same experiment was repeated in animals
which were put on high Ca diet after parathyroidectomy to
achieve higher serum calcium levels. Animals received Al-
tromin C 1000 diet with 1.6% Ca content (by addition of
CaCO3/CaHPO4 50/50 wt/wt).
Analytical techniques
Serum chemistry. Serum creatinine, calcium, phosphate and
total protein were measured using an Autoanalyzer. I ,25(OH),
D3 was measured after Extralut extraction using a radioimmu-
noassay [8].
Morphometric techniques. Kidneys were carefully removed
and temporarily embedded in agar. A random set of equidistant
slices (distance 0.75 mm) was prepared from the whole organ.
Orientation of sectioning was approximately normal to the axis
between the poles, All slices were embedded in Paraplast.
Sections of 4 sm thickness were stained with haematoxylin and
eosin. The cortical section area (Ac) and the total section area
(A0) were determined in each section with the semiautomatic
image analyzing system IBAS I (Kontron Co., Eching, Ger-
many) at a magnification of 10:1. The ratio A!A10 corre-
sponded to the volume density V of cortical tissue (cm3
cortical volume per cm3 total renal tissue volume) according to
Delesse's principle [9]. Cortical volume (CV) was derived from
V of cortical tissue, weight of kidney and specific weight (1.04
g/cm3) according to the relation: V,,, cortex X organ weight!
specific weight. The volume fraction of the proximal tubular
cells within the cortex (V: volume of cells per unit cortical
volume) was determined by means of a point counting proce-
dure [9]. Forty test areas were randomly selected from all
sections with sytematic area-weighted sampling. Counting was
performed with a Zeiss eyepiece containing 100 test points. The
proximal tubular cell volume was calculated by multiplication
of the V,, ratio with cortical volume. In addition, the number of
nuclear profiles of proximal tubular epithelial cells was counted
in each test area (45000 sm2). The number of cell nuclei per unit
cortical volume (Ny) was estimated according to the equation
where
n
Nv =t + D -2h)
n = number of counted section profiles,
A = reference sectional area,
= section thickness,
D = diameter of spherical objects, and
h = loss of small cap sections (truncation) due to contrast
deficiency.
Proximal tubular cell nuclei can be considered as spheres.
Measurements on nuclei revealed a diameter of approximately
8 m; the truncation effect was 2 m and section thickness was
4 tm. The total number of proximal tubular cell nuclei was
calculated by multiplication of N with the total cortical vol-
ume.
Note that in the case of mononuclear proximal tubular cells
the ratio of the total proximal tubular volume/total number of
proximal tubular cell nuclei is an estimator of the mean volume
of the cells.
Counting of miloses in renal tissue. In HE stained 8 i
sections of paraffin embedded tissue, mitoses were counted at
400 x magnification using a Zeiss Co. Integrationsplatte II
100/25. Mitoses were counted in 50 fields each in the cortex,
outer stripe, inner stripe and inner medulla using a systematic
random sampling technique.
Measurements of calbindin-D2,Sk in kidney tissue. UNX ani-
mals given solvent or 20 pmol!100 g body wt of I ,25(OH)2D3 by
daily s.c. injection were examined five days after surgery. For
the determination of CaBP content the kidney was rapidly
removed from uninephrectomized animals treated with
1,25(OH)2D3, frozen in liquid nitrogen and stored at —80°C.
The 100,000 g supernatants were prepared according to a
previously described technique [10]. CaBP was measured by
radioimmunoassay as reported previously [10] with antibodies
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Table 1. Stereological analysis of kidneys five days after
uninephrectomy
Sham
operated P UNX
Cortical volume cm3 0.687 0.0247 <0.02 0.8670 .0962
Volume fraction of prox. 0.47 10 .0278 <0.01 0.657 0.0482
tubular cells (as
fraction of cortical
volume)
Proximal tubular cell 128 23.3 <0.05 170 25.1
number (x 106) per
kidney
Average proximal 3672 278 NS 3862 319
tubular cell volume js
Table 2. Effect of l,25(OH)2D3 on compensatory renal growth after
uninephrectomy
Kidney wet
ratio (x Iweight (g)/body weight (g)Q5) days post-operative
3 5 7
UNX solvent 625 38 603 33 626 50
UNX + 1,25(OH)2D1 576 515 20C 534 36C
Sham operation solvent 513 74 472 24 471 12
Sham operation + 477 38 428 29 413 31
I ,25(OH)2D3
Eight animals per group; animals ad libitum fed; data as SD.
Difference between UNX and sham op animals P < 0.01
Difference between solvent and l,25(OH)2D1 b p < 0.01, C p<0.005
Eight animals per group; numbers are means of individual animals.
to rat kidney CaBP prepared in rabbits [11]. CaBP-D28k con-
centration has been expressed in terms of sg/mg of soluble
proteins.
Statistics
Data are given as x SD. Differences between groups were
examined using Wilcoxon's rank-sum test for random samples.
Results
Renal weight and renal morphology after uninephrectomy
While animal weight increased linearly with age, renal weight
failed to do so, and consequently renal (wet) weight/body
weight ratio decreased with age (Fig. 1). All subsequent exper-
iments on renal growth were carried out in animals which were
four weeks of age. Uninephrectomy caused a significant in-
crease of the renal wet weight/body weight ratio. The ratio
reached a plateau seven days after uninephrectomy. Body
weight was not altered by UNX nor were serum creatinine, Hb
and electrolytes (data not given).
It was the purpose of the study to analyze potential effects of
l,25(OH)2D3 on cell proliferation. To verify whether cell pro-
liferation, that is, hyperplasia, occurred in the rat after UNX,
we analyzed (experiment 2) cortical volume and proximal
tubular cell number using stereological techniques (Table 1).
Five days after UNX, a significant (P < 0.02) increase in
cortical volume, volume fraction of proximal tubular cells and
proximal tubular cell number with no change of average prox-
imal tubular cell volume was noted in UNX rats compared with
sham operated, ad libitum-fed control rats. Food consumption
was similar in the two groups.
Influence of! ,25(OH)2D3 treatment on renal weight
1 ,25(OH)2D3 in non-hypercalcemic doses significantly re-
duced the renal wet weight/body weight ratio in sham operated
solvent versus sham operated, treated ad libitum-fed animals
(Table 2).
Subcutaneous injection of 20 pmol l,25(OH)2D3 raised
plasma l,25(OH)2D3 concentration from 84 7.35 pg/liter at
baseline to 350 30.6 (2 hr), 422 12.6 (6 hr) and 108 2.89
(24 hr). The time-averaged l,25(OH)2D3 concentration (area
under the curve) was 3.3-fold higher than baseline concentra-
tion.
Table 3 shows that 1 ,25(OH)2D3 also lowered food consump-
tion and the food conversion ratio, that is, body weight gain per
unit weight of consumed food in UNX animals. This resulted in
a diminished percent increase in body weight. Renal dry weight
and percent increase of renal dry weight were significantly (P <
0.05) lower with I ,25(OH)2D5 treatment. When corrected for
body weight, the renal wet weight/body weight ratio was still
significantly lower (Table 2). The ratio of renal dry weight/body
weight (Table 3) was numerically lower but the difference
narrowly (P < 0.06) failed to reach statistical significance. This
result was confirmed in two independent experiments. No
difference in absolute weights or the organ weight/body weight
ratio was seen for spleen, heart, testis, femur and liver (data not
given).
To further evaluate the action of I ,25(OH)2D3 treatment on
kidneys, renal content of calbindin-D28k was examined.
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Fig. I. Body weight and kidney wet weight as
a function of animal age.
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Table 3. Effect of l,25(OH),D. on body weight and renal growth
after uninephrectomy
UNX UNX
solvent I .25(OH)0D1
Final body weight g
Percent body weight increase
Renal dry weight g
Percent increase in renal dry
weight"
Renal dry weight/body weight
ratio (X l0)
Time of surgery
Final
Percent increase
Food consumption g/8 days
Food consumption/body
weight ratio
Serum Ca ,nmol/!iter
Serum alkaline phosphatase U
Eight to 10 animals per group; animals ad libitum fed and examined 8
days after uninephrectomy.
a Percent increase of remaining kidney (day 8) compared with weight
of contralateral kidney (day 0)b Difference solvent vs. l,25(OH),D, P < 0.05
l,25(OH)2D3 treated animals but stayed within the normal
range.
To exclude the possibility that the low mitoses seen in
l,25(OH)2D3 treated animals were due to an artifact caused by
lower food intake, two further series were done in which
solvent-treated UNX animals received only 5 g and 6 g Al-
tromin C diet on day 0 and I after uninephrectomy versus 10 g
and 12 g in l,25(OH)2D3 treated animals. The two series gave
similar results, and the results of one series are summarized in
Figure 3. With l.25(OH)2D1 treatment, a significant decrease in
mitoses was found in the cortex (Fig. 3) as well as in the outer
stripe and inner stripe (data not given), despite the fact that
solvent treated animals had lost more body weight in the two
day experimental period (24.7 3.5 g) than did the 1,25(OH)2D3
treated animals (13.1 4.0 g). Low numbers of mitoses and no
significant effect of I .25(OH)2D1 were noted in the inner me-
dulla (21.4 9.3 vs. 19.8 10.5/mm2) in solvent treated
controls. Similarly, mitoses in glomeruli were low and influ-
enced neither by uninephrectomy nor by 1 ,25(OH)2D3 (day 2:
UNX + l,25(OH),D3 10.6 2.2/200 glomeruli vs. 10.1
1.96/200 glomeruli in UNX solvent; day 6 11.4 3.4 in UNX +
I ,25(OH)2D5 vs. 11.6 2.45 in UNX solvent). A tendency was
noted for lower mitoses to occur in kidneys of l,25(OH)2D3
treated, sham operated animals, that is, without UNX (data not
given).
Fig. 2. Kidney section in colchicin pretrealed animals. Note presence
of mitoses (marked by arrows). (HE x 500).
I ,25(OH)2D3 significantly (P < 0.05) increased calbindin (ng/mg
protein) from 4.39 0.39 to 6.127 0.44. No significant change
of serum creatinine (mg/dl) was noted (0.51 0.06 vs. 0.52
0.06).
Influence of] ,25(OH)2Dm treatment on mitoses in kidney
As shown in Figure 2, colchicin pretreatment permitted easy
detection of mitoses in HE-stained kidney sections.
Four-week-old animals were examined two days after UNX
or sham operation. The results were confirmed in three inde-
pendent series. In a first series, in animals on unrestricted food
intake, l,25(OH)2D3 treatment reduced food intake (mean 19
2.8 g12 days vs. 24 3.7 g/2 days in solvent treated controls).
Mitoses in total cortex as well as in proximal and distal tubules
are shown in Table 4. Very few mitoses were noted in glomer-
oh. Occasional mitoses were seen in interstitial cells, particu-
larly in the interspace between medullary structures and uroep-
ithelium. Serum calcium levels tended to be higher in
influence of / ,25(OH)2D3 treatment on mitoses in kidneys of
parathyroideciomized rats maintained on PTH by osmotic
minipump
In experiment 4 the chosen dose of PTH failed to fully correct
hypocalcemia in PTX animals both on normal and on high
calcium diet, but food intake and the increase of body weight
were not different from solvent controls (data not shown).
Appropriate function of minipumps was verified by inspection
at the end of the experiment.
Administration of I ,25(OH)2D1 caused slightly higher serum
calcium levels, but failed to correct the hypocalcemia. A
significant reduction of mitoses in animals on 1 ,25(OH)2D3 was
noted in the cortex, proximal tubules and distal tubules.
A significant correlation between serum calcium and mitoses
was not found in any of the groups. As shown in Table 4, lower
mitoses in l,25(OH)2D3 treated animals were associated with
higher serum calcium levels in PTX animals, No significant
increase of serum calcium was noted in I ,25(OH)2D3 treated
PT-intact animals, but despite this the number of mitoses was
lower.
Discussion
The present study provides evidence that I ,25(OH)2D3 inter-
feres with compensatory growth of the residual kidney after
uninephrectomy in young growing rats. This was demonstrated
by reduction of the number of mitoses in proximal tubules and
distal nephron segments. In addition, 1 ,25(OH)2D1 treated
animals had significantly less gain in renal wet weight, in the
renal wet weight/body weight ratio and in renal dry weight; the
increment of renal dry weight/body weight ratio was numeri-
cally lower but narrowly (P < 0.06) failed to reach statistical
significance.
161 15
18.4 7.5
0.232 0.020
59.5 7.5
107 3.9
151 21.9
40.9 17.6
146 8.2
0.2 0.016
148 19
15.2 6.5
0.207 0022m
45.8 10.5"
110 6.7
140 6.4
26.9 8.1
132 21.7
0.16 0.037
2.48 0.05 2.77 0.37
480 47.9 454 94.3
216 Maithias et a!: Vitamin D and renal growth
Table 4. Effect of 1 ,25(OH)2D3 treatment on mitoses in renal tissue after uninephrectomy: Comparison of PT-intact animals and PTX animals
(PTH-infusion by osmotic minipump)
rmal Ca diet
PTX
PT intact no Normal Ca diet High Ca diet
Solvent I ,25(OH)2D3Solvent I .25(OH),D, Solvent I ,25(OH)2D3
Final body weight g 122 11.3 116 9.4 171 5.2 173 13.6 162 21.6 172 29.4
Serum Ca mmol/liter 2.02 0.16 2.22 0.18 1.14 0.38 1.51 0.25 1.49 0.08 1.76 0.l8a
Mitoses per mm2 cortical area
Cortex total 329 39.5 192 34,0b 354 185 152 32.2a 152 36.2 95
Proximal tubule 254 26.8 138 19.8" 286 131 122 34.4k' 114 24.7 74.1 115b
Distal tubule 71.8 19.8 51.7 16.8" 68 30.7 30 6.3a 37.5 12.2 21.1 3.5"
Group size 7 to 10 animals, animals fed ad libitum.
Difference solvent vs l,25(OH)2D3 'P < 0.05, bp <
300
250
200
E
E
150
100
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0
Cortex (total) Prox. tubule Dist. tubule
Fig. 3. Effect of I ,25(OH)2D3 treatment on mitoses in kidneys afler
uninephrectomy. Symbols are: (El) solvent; () l,25(OH)2D,,. Mitoses
is per mm2 cortical area. There were nine animals per group; animals
were with restricted food intake. Animals were studied 2 days after
uninephrectomy. * Significant difference (P < 0.005) between solvent
and 1,25(OH)2D3.
Several potential artifacts were considered. Food intake is an
important modulator of mitotic activity in renal tissue [12].
Nonhypercalcemic doses of 1 ,25(OH)2D3 reduced both food
intake and the food conversion ratio [7]. This phenomenon was
reproducible in several independent series. To exclude an
artifact of lower food intake we compared I ,25(OH)2D1 treated,
ad libitum-fed animals with solvent treated controls which had
received less food. The difference in mitoses remained highly
significant. This observation clearly dissociates the effect of
I ,25(OH)2D1 treatment and low food intake, respectively.
In parathyroid intact animals it is impossible to distinguish
direct effects of I ,25(OH)2D3 and indirect effects mediated via
suppression of endogenous PTH. To circumvent this problem
we compared solvent treated and I ,25(OH)2D3 treated animals
which had undergone PTX and which were maintained on PTH
by osmotic minipump. Significant suppression of mitoses in
renal tissue by l,25(OH)2D1 was still noted in animals with
constant PTH. This observation excludes the possibility that
the effects of l,25(OH)2D1 are mediated by reciprocal changes
of PTH secretion. This point is of importance since Jobin and
Bonjour [6] had demonstrated that PTH influences renal growth
in an ablation model. It is also of interest that an altered
response of adenylate cyclase to PTH has been demonstrated
during compensatory renal growth [13].
In PTX animals the effects of I ,25(OH)2D3 were seen despite
subnormal serum calcium levels. PTX animals with l,25(OH)2
D3 treatment had lower mitoses; serum calcium concentrations,
by necessity, were higher. In PT intact animals, however,
I ,25(OH)2D3 caused a similar decrease of mitoses with no
significant increase in serum calcium concentration. Therefore
it is unlikely that the action of l,25(OH)2D3 was mediated by
changes in serum calcium. In the experiments of Jobin and
Bonjour [6] a positive correlation between compensatory renal
growth and plasma calcium was noted in animals given PTH or
I ,25(OH)D, while an inverse correlation was seen in intact
animals.
An important consideration is the choice of l,25(OH)2D3
dosage. A dose of 20 pmol per day was chosen since this dose
is slightly higher than the estimated daily rate of production of
l,25(OH)2D1 in the experiments of Hsu et al [14]. Furthermore,
in vitamin D-deficient rats, the dose of 20 pmol is slightly above
the dose which fully corrects hypocalcemia [6]. Measurements
of the time course of serum l,25(OH)2D3 levels after s.c.
injection of 1 ,25(OH)2D3 showed that serum concentrations
averaged over 24 hours (area under the curve) were higher
by a factor of approximately 3. It is therefore likely that
1,25(OH)2D3 levels in the present experiment reflect changes
within a physiologically relevant range. In addition, measure-
ments of renal calbindin-D28k clearly documented that the
chosen dose of I ,25(OH)2D3 acted on target tissues.
It is uncertain whether I ,25(OH)2D3 affects renal growth and
renal cell proliferation only when compensatory growth occurs
as seen after uninephrectomy. In several independent series a
slight, but statistically not significant, reduction of the number
of mitoses was also noted in kidneys of sham operated animals.
It is possible that the failure to achieve statistical significance is
caused by the limited sensitivity of the method used when
applied to tissues with low basal mitotic activity. Consequently,
an effect of 1,25(OH)2D3 on normal postnatal growth of the
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kidney is not excluded. After uninephrectomy, renal growth is
selectively stimulated; the gain of renal weight may therefore be
particularly susceptible to suppression by 1,25(OH)7D3. In
other organs, no effect of I ,25(OH)2D3 on organ weight was
noted. This does not necessarily imply that the effect of
1,25(OH)2D3 is restricted to the kidney. To demonstrate an
effect of I ,25(OH)2D3 it may be necessary to stimulate growth,
for example, of the liver by partial hepatectomy.
One further finding of the present study deserves comment. It
has recently been found that hypertrophy is a major mechanism
underlying compensatory renal growth in ablation models [15,
16]. This is based on observations in adult animals, where 80%
of kidney growth following uninephrectomy is accounted for by
hypertrophy predominantly of proximal tubular cells [17, 18]. In
mice transient expression of Egr-l, an immediate early gene,
has been demonstrated after uninephrectomy [19]. Compensa-
tory renal hypertrophy is characterized by increased kidney
ribosome content and increased overall rate of rRNA gene
transcription [20, 21]. In this context, inhibition of renal RNA
polymerase I and II by high doses of I ,25(OH)2D3 may also be
of interest [22].
In our experiments, stereological analysis of kidneys five
days after uninephrectomy showed increased numbers of prox-
imal tubular cells with no change of average proximal tubular
cell volume, that is, hyperplasia with no detectable hypertro-
phy. We emphasize that we used young growing rats in which
spontaneous renal growth [23] and growth after surgical abla-
tion [24] occurs mainly through hyperplasia. The results in the
present study cannot be extrapolated to nongrowing animals.
The finding that I ,25(OH)2D3 interferes with compensatory
renal growth in vivo would be in line with previous observations
which documented that 1 ,25(OH)2D3 has antiproliferative ac-
tions on numerous cell lines both non-malignant [3] and malig-
nant [1, 2, 25], including renal cell carcinoma lines [1]. Renal
tissue binds 1 ,25(OH)2D3 as shown by autoradiographic studies
of Stumpf et al [26], and is further documented by binding
studies [27] or by immunohistochemical demonstration of the
I ,25(OH)2D3 receptor molecule [28]. 1 ,25(OH)2D3 receptors are
crucial to mediating the effect of vitamin D on target organs.
Furthermore, previous authors speculated that expression of
1 ,25(OH)2D3 receptors in the kidney may change during com-
pensatory renal growth [6]. This prompted us to measure
specific binding of 3H I ,25(OH)2D5 in chromatin fractions of
renal tissue (data not given). No major change in specific
binding was noted after uninephrectomy, but the biological
relevance of this finding is unknown given the changes of
cellular composition of the kidneys following uninephrectomy.
In the present study, reduction of mitoses in tubules (but not
glomeruli and medullary structures) and diminution of renal
weight gain was noted in uninephrectomized animals following
treatment with 1,25(OH)2D3. This is in apparent conflict with
previous findings of Jobin and Bonjour [61, who noted signifi-
cant stimulation of compensatory renal growth, assessed by
kidney weight, RNA and DNA gains and 3H-thymidine incor-
poration, following administration of l,25(OH)2D3 to vitamin
D-depleted Wistar rats. The two studies differ in several re-
spects. We used faster growing Sprague-Dawley rats and nor-
malized renal (dry) weight for body weight gain [which is
influenced by l,25(OH)2D3]. The most salient difference, how-
ever, is our use of vitamin D-repleted animals. This may be
important since we have recently been able to show [5] that in
chondrocytes, low concentrations of 1,25(OH),D3 stimulated
growth and 3H thymidine incorporation in the presence of
charcoal-stripped FCS, that is, in the absence of vitamin D
metabolites. In contrast, higher concentrations dose-depen-
dently inhibited chondrocyte proliferation [5]. This finding
implies opposite effects of l,25(OH)2D3 on cell proliferation
depending on baseline I ,25(OH)2D3 concentration and 1,25
(OH)2D5 dose.
The physiological importance of presumed modulation of
renal cell proliferation during compensatory renal growth by
l,25(OH),D3 is unknown. It is intriguing, however, to speculate
that I ,25(OH)2D1 which is synthesized in proximal tubular cells
modulates renal cell growth by autocrine and/or paracrine
actions. One could also hypothesize that the transient fall in
circulating l,25(OH),D3 levels as noted by some investigators
in patients after uninephrectomy [29, 30] favors compensatory
growth of the kidney by disinhibiting cells from the constraining
effects of I ,25(OH)2D5. Whether low circulating 1,25 (OH)2D5
levels in renal failure favor compensatory growth of residual
nephrons (and whether conversely administration of
1 ,25(OH)D3 interferes with this process) deserves further
study.
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